🔗 Permalink

Inventor profile of:

Michael Milone

City:

Cherry Hill, New Jersey

Country:

United States

Published Applications:

Last publication date:

2024-10-17

Top Assignees for applications by Michael Milone

The entities that hold a legal rights for patent applications filed by inventor Milone Michael:

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 8 PHILADELPHIA, PA United States
NOVARTIS AG 6 Basel, Switzerland
Jennifer Brogdon 2 Cambridge, MA United States
David Glass 2 Cambridge, MA United States
Wayne State University 2 Detroit, MI United States
Carl H. June 1 Merion Station, PA United States
Joan Mannick 1 Cambridge, MA United States
Michael J. Milone 1 Cherry Hill, NJ United States
Huijuan H. Song 1 Shanghai, PA China
Abhishnek Garg 1 Cambridge, MA United States
Qilong H. Wu 1 Basel, PA Switzerland
Qilong H. Wu 1 Philadelphia, PA United States
Gabriela H. Plesa 1 Blue Bell, PA United States
Corin Dorfmeier 1 Hayfield, PA United States
Nicholas J. Wilcox 1 Southlake, TX United States
Leon H. Murphy 1 Cambridge, MA United States
Michael H. Milone 1 Cherry Hill, NJ United States
Leon J. Murphy 1 Cambridge, MA United States
Elena J. Orlando 1 Somerville, MA United States
Gregory Beatty 1 Philadelphia, PA United States
Jan J. Melenhorst 1 Cherry Hill, NJ United States
Felipe Bedoya 1 Medford, MA United States
Hans Bitter 1 Lincoln, MA United States
Qilong H. Wu 1 Shanghai, PA China
Joan H. Mannick 1 Cambridge, MA United States

Recent patent applications by Milone Michael

Michael Milone from Cherry Hill, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-17

US20240342213A1

Human necessities

Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule

#2 | 2024-01-25

US20240026293A1

Chemistry; metallurgy

Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule

#3 | 2022-06-16

US20220184129A1

Human necessities

Compositions and Methods Comprising a High Affinity Chimeric Antigen Receptor (CAR) with Cross-Reactivity to Clinically-Relevant EGFR Mutated Proteins

#4 | 2018-11-22

US20180334490A1

Chemistry; metallurgy

METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY

#5 | 2018-11-01

US20180312595A1

Chemistry; metallurgy

Treatment of cancer using a CD123 chimeric antigen receptor

#6 | 2018-10-04

US20180282693A1

Chemistry; metallurgy

Methods and compositions for cells expressing a chimeric intracellular signaling molecule

#7 | 2018-08-30

US20180243341A1

Human necessities

Methods and compositions for cells expressing a chimeric intracellular signaling molecule

#8 | 2018-01-25

US20180022795A1

Chemistry; metallurgy

Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

#9 | 2017-10-26

US20170306416A1

Chemistry; metallurgy

Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof

#10 | 2017-09-14

US20170260268A1

Chemistry; metallurgy

Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

#11 | 2017-05-18

US20170137783A1

Chemistry; metallurgy

Methods for improving the efficacy and expansion of immune cells

#12 | 2016-10-27

US20160311907A1

Chemistry; metallurgy

Regulatable chimeric antigen receptor

InventorID:

1690983 ⎘